The Greater Cannabis Company GCAN Stock
The Greater Cannabis Company Price Chart
The Greater Cannabis Company GCAN Financial and Trading Overview
| The Greater Cannabis Company stock price | 0.0005 USD |
| Previous Close | 0.00067 USD |
| Open | 0.0005 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0005 - 0.00067 USD |
| 52 Week Range | 0.0003 - 0.0025 USD |
| Volume | 67.35K USD |
| Avg. Volume | 553.65K USD |
| Market Cap | 490.87K USD |
| Beta (5Y Monthly) | 1.27649 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GCAN Valuation Measures
| Enterprise Value | 751.86K USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -4.447 |
Trading Information
The Greater Cannabis Company Stock Price History
| Beta (5Y Monthly) | 1.27649 |
| 52-Week Change | -55.33% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.0025 USD |
| 52 Week Low | 0.0003 USD |
| 50-Day Moving Average | 0.0005694 USD |
| 200-Day Moving Average | 0.0006678 USD |
GCAN Share Statistics
| Avg. Volume (3 month) | 553.65K USD |
| Avg. Daily Volume (10-Days) | 932.81K USD |
| Shares Outstanding | 732.64M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 60.73% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -33.39% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -169073 USD |
| Net Income Avi to Common (ttm) | -255650 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 251.55K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 503.44K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.296 |
| Book Value Per Share (mrq) | -0.001 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -116036 USD |
| Levered Free Cash Flow (ttm) | -42855 USD |
Profile of The Greater Cannabis Company
| Country | United States |
| State | MD |
| City | Baltimore |
| Address | 2833 Smith Avenue |
| ZIP | 21209 |
| Phone | 443 738 4051 |
| Website | https://www.gcanrx.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 1 |
The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson's disease, Alzheimer's disease, and other neuropsychiatric disorders. The Greater Cannabis Company, Inc. was founded in 2014 and is based in Baltimore, Maryland.
Q&A For The Greater Cannabis Company Stock
What is a current GCAN stock price?
The Greater Cannabis Company GCAN stock price today per share is 0.0005 USD.
How to purchase The Greater Cannabis Company stock?
You can buy GCAN shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for The Greater Cannabis Company?
The stock symbol or ticker of The Greater Cannabis Company is GCAN.
Which industry does the The Greater Cannabis Company company belong to?
The The Greater Cannabis Company industry is Drug Manufacturers-Specialty & Generic.
How many shares does The Greater Cannabis Company have in circulation?
The max supply of The Greater Cannabis Company shares is 804.64M.
What is The Greater Cannabis Company Price to Earnings Ratio (PE Ratio)?
The Greater Cannabis Company PE Ratio is now.
What was The Greater Cannabis Company earnings per share over the trailing 12 months (TTM)?
The Greater Cannabis Company EPS is 0 USD over the trailing 12 months.
Which sector does the The Greater Cannabis Company company belong to?
The The Greater Cannabis Company sector is Healthcare.